Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 205,000.0 | $2.6M | 1.49% | NEW | — | $12.52 | +12.9% |
| 22 | PROF | PROFOUND MED CORP | Healthcare | 285,710.0 | $2.2M | 1.30% | NEW | — | $7.87 | -13.2% |
| 23 | KZIA | KAZIA THERAPEUTICS LTD | Healthcare | 300,000.0 | $2.1M | 1.20% | NEW | — | $6.89 | +98.3% |
| 24 | RZLT | REZOLUTE INC | Healthcare | 750,000.0 | $1.8M | 1.03% | NEW | — | $2.36 | +37.7% |
| 25 | — | TENAX THERAPEUTICS INC | — | 83,333.0 | $1.0M | 0.59% | NEW | — | $12.19 | — |
| 26 | — | EDESA BIOTECH INC | — | 687,500.0 | $976K | 0.57% | NEW | — | $1.42 | — |
| 27 | — CALL | TREVI THERAPEUTICS INC | — | 38,500.0 | $482K | 0.28% | NEW | — | $12.52 | — |
| 28 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 6,500.0 | $432K | 0.25% | NEW | — | $66.39 | +12.9% |
| 29 | — | VENTYX BIOSCIENCES INC | — | 40,000.0 | $361K | 0.21% | NEW | — | $9.03 | — |
| 30 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 80,000.0 | $341K | 0.20% | NEW | — | $4.26 | -11.7% |
| 31 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,700.0 | $323K | 0.19% | NEW | — | $87.34 | +13.6% |
| 32 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 16,000.0 | $304K | 0.18% | NEW | — | $18.97 | -7.7% |
| 33 | OVID | OVID THERAPEUTICS INC | Healthcare | 160,000.0 | $261K | 0.15% | NEW | — | $1.63 | +51.5% |
| 34 | GOSS | GOSSAMER BIO INC | Healthcare | 70,000.0 | $217K | 0.13% | NEW | — | $3.10 | -93.2% |
| 35 | IMNM | IMMUNOME INC | Healthcare | 10,000.0 | $215K | 0.12% | NEW | — | $21.48 | +0.8% |
| 36 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 20,000.0 | $188K | 0.11% | NEW | — | $9.38 | +17.0% |
| 37 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 35,000.0 | $183K | 0.11% | NEW | — | $5.23 | +67.9% |
| 38 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 100,000.0 | $147K | 0.09% | NEW | — | $1.47 | +76.9% |
| 39 | REPL | REPLIMUNE GROUP INC | Healthcare | 15,000.0 | $146K | 0.09% | NEW | — | $9.72 | -49.5% |
| 40 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 33,000.0 | $126K | 0.07% | NEW | — | $3.81 | -9.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%